By Nehla P Department of Pharmaceutical Chemistry Grace College of Pharmacy
By Nehla P Department of Pharmaceutical Chemistry Grace College of Pharmacy
By Nehla P Department of Pharmaceutical Chemistry Grace College of Pharmacy
By
Nehla p
Department of Pharmaceutical Chemistry
Grace college of pharmacy
QUANTITATIVE STRUCTURE
ACTIVITY RELATIONSHIP
It is said to be a mathematical relationship in the form
of an equation between the biological activity and
measurable physiochemical parameters.
Partition coefficient:
P=[drug] in octanol/[drug] in water
Log (1/C)
. . .
.
.. . . . Log1C = k1 logP + k2
Log (1/C)
1
Log C = - k1 (logP) 2 + k2logP + k3
o
Log P Log P
Example : Cl
Log P(theory) = log P(benzene) + pCl + pCONH2
= 2.13 + 0.71 - 1.49
= 1.35
CONH2
Log P (observed) = 1.51
meta-Chlorobenzamide
Charge is stabilised by X
Equilibrium shifts to right KX > KH
X = electron
withdrawing X X
group CO2H CO2 + H
Charge destabilised
Equilibrium shifts to left KX < KH
meta-Substitution
O
N
O e-withdrawing (inductive effect only)
DRUG
para-Substitution
O O O O O O O O
N N N N
e-withdrawing
(inductive +
resonance effects)
DRUG DRUG DRUG DRUG
Hammett Substituent Constant (s)
meta-Substitution
OH
para-Substitution
OH OH OH OH
e-donating by resonance
more important than
inductive effect
DRUG DRUG DRUG DRUG
STERIC SUBSTITUTION CONSTANT
It is a measure of the bulkiness of the group it
represents and it effects on the closeness of contact
between the drug and receptor site. It is much harder
to quantitate.
Es = log kx - log ko
kx represents the rate of hydrolysis of a substituted ester
ko represents the rate of hydrolysis of the parent ester
Molar refractivity (MR)--measure of the volume
occupied by an atom or group--equation includes
the MW, density(d), and the index of
refraction(n)–
MR=(n²-1)MW/(n²+2)d
CH CH2 NRR'
1
Log C = 1.22 p - 1.59 s + 7.89
Conclusions:
• Activity increases if p is +ve (i.e. hydrophobic substituents)
• Activity increases if s is negative (i.e. e-donating substituents)
Free-Wilson Approach
Method
Docking Software
DOCK – Kuntz
Flex – Lengauer
LigandFit – MSI Catalyst
COMPARITIVE MOLECULAR FIELD
ANALYSIS
CoMFA involves placing of molecules in a grid and to
correlate field properties of the molecules with
biological activities.
Dick Crammer in 1988
Steps
1. Group of compounds having a common
pharmacophore is selected .
2. The 3-dimensional structures of reasonable
conformation must be generated from 2-dimensional
structures.
22
CoMFA
23
PHARMACOPHORE SELECTION
CO2 H
CH3
+ H +
d1 PD
NH d1 NH
PD
CH3
L H L
d2 d3 HO d2 d3
N
D
H D
OH
d1 PD
L L-LIPOPHILIC SITE
d2 d3
D-H- BOND DONOR
D
PD-PROTONATED H-
PHARMACOPHORE BOND DONOR
24
Identification Of Pharmacophore
OH
HO NHCH3
Build 3D
HO
model
Active conformation Define pharmacophore
25
CoMFA ALIGNMENT
MeO d3 OMe
OH LA BL
L d1 C
L1 d2
d3 D
d3 L
d2 Cl Cl
LA B Cl
C
L7 d2
HO d1 L
d1 L
"Pharmacophore"
L
C
OH
OH O L d3
d3 B d2
NMe2
L
A d2 C
L1
L
A d1 B
d1 CL7
HO O HO O
26
CoMFA
5. Once molecules are aligned, a grid or lattice is
established which surrounds the sets of analogues in
potential receptor space.
27
CoMFA
•Place the pharmacophore into a lattice of grid points
Grid points
28
CoMFA
•Position molecule to match the pharmacophore
Grid points
30
•A probe atom is placed at each grid point in turn
.
. Probe atom
. .
.